Biomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair

Stem Cell Research and Therapy

Volumn 4, Issue 6, 2013, Pages

  Zimmermann, Wolfram Hubertus ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VISCOSITY; BLOOD VOLUME; CELL PROLIFERATION; CELL SURVIVAL; HEART AFTERLOAD; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REVASCULARIZATION; HEART MUSCLE TENSION; HEART PRELOAD; HEART SURGERY; HEART WORK; HEMODYNAMICS; HUMAN; HYDROSTATIC PRESSURE; METABOLIC CAPACITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; VASCULAR RESISTANCE; VISCOELASTICITY;

ANIMALS; CELL DIFFERENTIATION; HEART; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; REGENERATION; TISSUE ENGINEERING;

EID: 84887909299     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt348     Document Type: Review

References (54)

1. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE, Nat Mater 2008 7 1003 1010 10.1038/nmat2316 18978786
2. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA, Nat Med 2008 14 213 221 10.1038/nm1684 18193059 (Pubitemid 351214548)
3. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Bursac N, Papadaki M, Cohen RJ, Schoen FJ, Eisenberg SR, Carrier R, Vunjak-Novakovic G, Freed LE, Am J Physiol 1999 277 433 H444 10444466
4. Construction of a bioengineered cardiac graft. Li RK, Yau TM, Weisel RD, Mickle DA, Sakai T, Choi A, Jia ZQ, J Thorac Cardiovasc Surg 2000 119 368 375 10.1016/S0022-5223(00)70193-0 10649213 (Pubitemid 30091810)
5. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S, Circulation 2000 102 II56 III61 11082363
6. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wakatsuki T, Elson EL, FASEB J 1997 11 683 694 9240969 (Pubitemid 27318285)
7. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T, Biotechnol Bioeng 2000 68 106 114 10.1002/(SICI)1097-0290(20000405)68:1<106:: AID-BIT13>3.0.CO;2-3 10699878 (Pubitemid 30163499)
8. Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle. Soong PL, Tiburcy M, Zimmermann WH, Curr Protoc Cell Biol 2012 23 23 28
9. A modular approach to cardiac tissue engineering. Leung BM, Sefton MV, Tissue Eng Part A 2010 16 3207 3218 10.1089/ten.tea.2009.0746 20504074
10. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T, Circulat Res 2002 90 40 10.1161/hh0302.105722 11861428
11. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Kelm JM, Djonov V, Hoerstrup SP, Guenter CI, Ittner LM, Greve F, Hierlemann A, Sanchez-Bustamante CD, Perriard JC, Ehler E, Fussenegger M, Tissue Eng 2006 12 2541 2553 10.1089/ten.2006.12.2541 16995787 (Pubitemid 46141277)
12. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. Schaaf S, Shibamiya A, Mewe M, Eder A, Stohr A, Hirt MN, Rau T, Zimmermann WH, Conradi L, Eschenhagen T, Hansen A, PLoS One 2011 6 26397 10.1371/journal.pone.0026397 22028871
13. Adenovirus-delivered short hairpin RNA targeting PKC improves contractile function in reconstituted heart tissue. El-Armouche A, Singh J, Naito H, Wittkopper K, Didie M, Laatsch A, Zimmermann WH, Eschenhagen T, J Mol Cell Cardiol 2007 43 371 376 10.1016/j.yjmcc.2007.05.021 17628588 (Pubitemid 47301932)
14. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. de Lange WJ, Hegge LF, Grimes AC, Tong CW, Brost TM, Moss RL, Ralphe JC, Circulat Res 2011 109 8 19 10.1161/CIRCRESAHA.111. 242354 21566213
15. Transplantation of a tissue-engineered human vascularized cardiac muscle. Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S, Gepstein L, Tissue Eng Part A 2010 16 115 125 19642856
16. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T, Nat Med 2006 12 452 458 10.1038/nm1394 16582915
17. Derivation and potential applications of human embryonic stem cells. Gepstein L, Circulat Res 2002 91 866 876 10.1161/01.RES.0000041435.95082.84 12433831 (Pubitemid 35373586)
18. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Tiburcy M, Didie M, Boy O, Christalla P, Doker S, Naito H, Karikkineth BC, El-Armouche A, Grimm M, Nose M, Eschenhagen T, Zieseniss A, Katschinksi DM, Hamdani N, Linke WA, Yin X, Mayr M, Zimmermann WH, Circ Res 2011 109 1105 1114 10.1161/CIRCRESAHA.111.251843 21921264
19. Cardiomyocyte proliferation contributes to heart growth in young humans. Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, Silberstein LE, Dos Remedios CG, Graham D, Colan S, Kuhn B, Proc Natl Acad Sci U S A 2013 110 1446 1451 10.1073/pnas.1214608110 23302686
20. Cardiac grafting of engineered heart tissue in syngenic rats. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T, Circulation 2002 106 151 I157 12354725
21. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Fink C, Ergun S, Kralisch D, Remmers U, Weil J, Eschenhagen T, FASEB J 2000 14 669 679 10744624 (Pubitemid 30198566)
22. Tissue engineering of a differentiated cardiac muscle construct. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T, Circ Res 2002 90 223 230 10.1161/hh0202.103644 11834716 (Pubitemid 34627092)
23. Evaluation of left ventricular torsion by cardiovascular magnetic resonance. Young AA, Cowan BR, J Cardiovasc Magn Reson 2012 14 49 10.1186/1532-429X-14-49 22827856
24. Molecular basis of physiological heart growth: fundamental concepts and new players. Maillet M, van Berlo JH, Molkentin JD, Nat Rev Mol Cell Biol 2013 14 38 48 23258295
25. Evidence for cardiomyocyte renewal in humans. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J, Science 2009 324 98 102 10.1126/science. 1164680 19342590
26. Fluid dynamics of heart development. Santhanakrishnan A, Miller LA, Cell Biochem Biophys 2011 61 1 22 10.1007/s12013-011-9158-8 21327946
27. The influence of the interval between beats on myocardial contractility. Koch-Weser J, Blinks JR, Pharmacol Rev 1963 15 601 652 14064358
28. The Frank-Starling mechanism in vertebrate cardiac myocytes. Shiels HA, White E, J Exp Biol 2008 211 2005 2013 10.1242/jeb.003145 18552289
29. Differential cardiac remodeling in preload versus afterload. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS, Hasenfuss G, Circulation 2010 122 993 1003 10.1161/CIRCULATIONAHA.110.943431 20733099
30. Idiopathic constriction of the fetal ductus arteriosus. Trevett TN Jr, Cotton J, Ultrasound Obstet Gynecol 2004 23 517 519 10.1002/uog.980 15133807 (Pubitemid 38639534)
31. Development gone awry: congenital heart disease. Gruber PJ, Epstein JA, Circulat Res 2004 94 273 283 10.1161/01.RES.0000116144.43797.3B 14976138 (Pubitemid 38240718)
32. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. Tobita K, Liu LJ, Janczewski AM, Tinney JP, Nonemaker JM, Augustine S, Stolz DB, Shroff SG, Keller BB, Am J Physiol Heart Circ Physiol 2006 291 1829 H1837 10.1152/ajpheart.00205. 2006 16617136 (Pubitemid 44497690)
33. Growth of engineered human myocardium with mechanical loading and vascular coculture. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE, Circ Res 2011 109 47 59 10.1161/CIRCRESAHA.110.237206 21597009
34. Cardiac plasticity. Hill JA, Olson EN, N Engl J Med 2008 358 1370 1380 10.1056/NEJMra072139 18367740 (Pubitemid 351468414)
35. Contribution of extracellular matrix to the mechanical properties of the heart. Fomovsky GM, Thomopoulos S, Holmes JW, J Mol Cell Cardiol 2010 48 490 496 10.1016/j.yjmcc.2009.08.003 19686759
36. Matrix elasticity directs stem cell lineage specification. Engler AJ, Sen S, Sweeney HL, Discher DE, Cell 2006 126 677 689 10.1016/j.cell.2006.06.044 16923388 (Pubitemid 44233625)
37. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Kattman SJ, Adler ED, Keller GM, Trends Cardiovasc Med 2007 17 240 246 10.1016/j.tcm.2007.08.004 17936206 (Pubitemid 47532729)
38. Cardiac tissue engineering for replacement therapy. Zimmermann WH, Eschenhagen T, Heart Fail Rev 2003 8 259 269 10.1023/A:1024725818835 12878835 (Pubitemid 36992440)
39. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Barbone A, Holmes JW, Heerdt PM, The AH, Naka Y, Joshi N, Daines M, Marks AR, Oz MC, Burkhoff D, Circulation 2001 104 670 675 10.1161/hc3101.093903 11489773 (Pubitemid 32738521)
40. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, Taegtmeyer H, Nat Med 1998 4 1269 1275 10.1038/3253 9809550 (Pubitemid 28512107)
41. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Sekine H, Shimizu T, Sakaguchi K, Dobashi I, Wada M, Yamato M, Kobayashi E, Umezu M, Okano T, Nat Commun 2013 4 1399 23360990
42. Cardiac tissue engineering using perfusion bioreactor systems. Radisic M, Marsano A, Maidhof R, Wang Y, Vunjak-Novakovic G, Nat Protoc 2008 3 719 738 10.1038/nprot.2008.40 18388955 (Pubitemid 351516766)
43. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH, Circulation 2006 114 72 I78 16820649
44. Parthenogenetic stem cells for tissue-engineered heart repair. Didie M, Christalla P, Rubart M, Muppala V, Doker S, Unsold B, El-Armouche A, Rau T, Eschenhagen T, Schwoerer AP, Ehmke H, Schumacher U, Fuchs S, Lange C, Becker A, Tao W, Scherschel JA, Soonpaa MH, Yang T, Lin Q, Zenke M, Han DW, Scholer HR, Rudolph C, Steinemann D, Schlegelberger B, Kattman S, Witty A, Keller G, Field LJ, Zimmermann WH, J Clin Invest 2013 123 1285 1298 10.1172/JCI66854 23434590
45. Modeling myocardial growth and hypertrophy in engineered heart muscle. Tiburcy M, Zimmermann WH, Trends Cardiovasc Med 2013 2013 2013
46. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Holubarsch C, Ruf T, Goldstein DJ, Ashton RC, Nickl W, Pieske B, Pioch K, Ludemann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D, Circulation 1996 94 683 689 10.1161/01.CIR.94.4.683 8772688 (Pubitemid 26289222)
47. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, Loffler E, Weichenhan D, Zimmermann W, Eschenhagen T, Koch WJ, Katus HA, J Gene Med 2004 6 387 394 15079813 (Pubitemid 40232985)
48. Myocardial regeneration for heart failure. Sawa Y, Nihon Rinsho 2010 68 719 725 20387567
49. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Streckfuss-Bomeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hubscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schon MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K, Eur Heart J 2013 34 2618 2629 10.1093/eurheartj/ehs203 22798560
50. Geron gets green light for human trial of ES cell-derived product. Alper J, Nat Biotechnol 2009 27 213 214 19270655
51. Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy. Chapman AR, Scala CC, Kennedy Inst Ethics J 2012 22 243 261 10.1353/ken.2012.0013 23285793
52. Embryonic stem cell trials for macular degeneration: a preliminary report. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R, Lancet 2012 379 713 720 10.1016/S0140-6736(12)60028-2 22281388
53. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D, Nature 2012 485 593 598 10.1038/nature11044 22522929
54. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Burridge PW, Keller G, Gold JD, Wu JC, Cell Stem Cell 2012 10 16 28 10.1016/j.stem.2011.12.013 22226352